{"url_path":"/sec/igc/8-k/2026-07-06/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-06","source_url":"https://www.sec.gov/Archives/edgar/data/1326205/0001185185-26-002808-index.html","accession_number":"0001185185-26-002808","cik":"0001326205","ticker":"IGC","issuer_name":"IGC Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1326205/0001185185-26-002808-index.html","primary_entity_key":"0001326205","primary_entity_name":"IGC Pharma, Inc."},"word_count":96,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\n**Exhibit No.**\n \n**Description**\n\n10.1\n \n[Form of Stock Purchase Agreement, dated June 30, 2026, by and between IGC Pharma, Inc. and each of Ram Mukunda and Claudia Grimaldi.](igcex10-1.htm)\n\n104\n  \nCover Page Interactive Data File, formatted in Inline XBRL\n\n \n\n1\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned, hereunto duly authorized.\n\n \n\n \n**IGC Pharma,\nInc.**\n\n \n \n \n\nDated:\nJuly 6, 2026\n \n \n\n \nBy:\n/s/ Ram\nMukunda\n\n \n \nName: \nRam Mukunda\n\n \n \nTitle:\nChief Executive Officer\n\n \n\n2"}